新农股份(002942) - 2025年3月10日至13日投资者关系活动记录表

Group 1: Market Insights - The recent increase in the price of chlorpyrifos is attributed to tight supply from upstream intermediate manufacturers and seasonal stocking demands, leading to a notable price rise for the raw material [2] - The company maintains a good cooperative relationship with upstream raw material suppliers, which mitigates the impact of raw material price increases, ensuring stable product supply [2] Group 2: Product Performance - The thiazole zinc series, particularly the product "Bisheng® Thiazole Zinc," has been recognized as a leading product in the industry since its launch in 2009, focusing on six core crops and maintaining stable growth [3] - The market share of "Bisheng® Thiazole Zinc" in its core crop segment is still relatively low, indicating significant potential for market share enhancement [3] Group 3: Product Structure and Market Strategy - Approximately 60% of the company's formulation business consists of innovative drug products, with the remainder being generic drugs and biopesticides, primarily targeting the domestic market while also expanding into overseas markets [3] - The overseas strategy for "Bisheng® Thiazole Zinc" focuses on Southeast Asia, leveraging partnerships with multinational companies and local agrochemical firms to achieve gradual internationalization [3] Group 4: Business Model and Supply Chain - The company adheres to a "differentiation" strategy and an "integrated model centered on formulations," ensuring stable supply of key intermediates and core raw materials while enhancing quality and efficiency [3] - The integrated model fosters strategic collaboration with key customers, which is crucial for long-term business success [4]